Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Deficit (Details)

v3.24.3
Stockholders’ Deficit (Details) - USD ($)
 1 Months Ended 9 Months Ended
Jul. 11, 2023
Jul. 31, 2021
Sep. 30, 2024
Dec. 31, 2023
Jun. 26, 2023
Stockholders’ Deficit [Line Items]          
Common stock, shares authorized     400,000,000 200,000,000  
Common stock, par value (in Dollars per share)     $ 0.001 $ 0.001  
Common stock share issued     97,858,406 34,756,049  
Exchange for cash price, per unit (in Dollars per share)   $ 5      
Shares of common stock 43,649   736,773    
Convertible debt shares granted     184,193    
Warrant [Member]          
Stockholders’ Deficit [Line Items]          
Shares warrants   4,000,000 47,852,430    
Exchange for cash price, per unit (in Dollars per share)   $ 0.0125      
Warrants term   5 years 5 years    
Exercise price per warrant (in Dollars per share)   $ 6 $ 6    
Purchase of additional warrants   600,000      
Proceeds of warrants (in Dollars)   $ 7,500      
Common Stock [Member]          
Stockholders’ Deficit [Line Items]          
Exchange for cash price, per unit (in Dollars per share)   $ 4.99      
Auto-conversion of the series A preferred stock         19,516,205
Series A-2 Preferred Stock [Member]          
Stockholders’ Deficit [Line Items]          
Auto-conversion of the series A preferred stock         43,649
IPO [Member]          
Stockholders’ Deficit [Line Items]          
Common stock share issued   5,000,000